Evidence map›Paper›PMID 35924033›Full record

ArticleMicrosystems & nanoengineering2022

Deposition chamber technology as building blocks for a standardized brain-on-chip framework.

B G C Maisonneuve, L Libralesso, L Miny, A Batut, J Rontard, M Gleyzes, B Boudra, J Viera, D Debis, F Larramendy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Microsystems & nanoengineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Modeling Neurodegenerative Diseases UsingFrontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

B G C MaisonneuveUniversity Grenoble Alpes, CNRS, LTM, 38000 Grenoble, France.ORCID 0000-0001-6961-3671
L LibralessoUniversity Grenoble Alpes, CNRS, GSCOP, 38000 Grenoble, France.
L MinyNETRI, 69007 Lyon, France.
A BatutNETRI, 69007 Lyon, France.
J RontardNETRI, 69007 Lyon, France.
M GleyzesNETRI, 69007 Lyon, France.
B BoudraNETRI, 69007 Lyon, France.
J VieraNETRI, 69007 Lyon, France.
D DebisNETRI, 69007 Lyon, France.
F LarramendyUniversity Grenoble Alpes, CNRS, LTM, 38000 Grenoble, France.
V JostUniversity Grenoble Alpes, CNRS, GSCOP, 38000 Grenoble, France.
T HoneggerUniversity Grenoble Alpes, CNRS, LTM, 38000 Grenoble, France.ORCID 0000-0002-1716-7363
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The in vitro modeling of human brain connectomes is key to exploring the structure-function relationship of the central nervous system. Elucidating this intricate relationship will allow better studying of the pathological mechanisms of neurodegeneration and hence result in improved drug screenings for complex neurological disorders, such as Alzheimer's and Parkinson diseases. However, currently used in vitro modeling technologies lack the potential to mimic physiologically relevant neural structures. Herein, we present an innovative microfluidic design that overcomes one of the current limitations of in vitro brain models: their inability to recapitulate the heterogeneity of brain regions in terms of cellular density and number. This device allows the controlled and uniform deposition of any cellular population within unique plating chambers of variable size and shape. Through the fine tuning of the hydrodynamic resistance and cell deposition rate, the number of neurons seeded in each plating chamber can be tailored from a thousand up to a million. By applying our design to so-called neurofluidic devices, we offer novel neuro-engineered microfluidic platforms that can be strategically used as organ-on-a-chip platforms for neuroscience research. These advances provide essential enhancements to in vitro platforms in the quest to provide structural architectures that support models for investigating human neurodegenerative diseases.

Indexed as

Electrical and electronic engineeringMicrofluidics

Identifiers

PMID35924033
PMCPMC9339542
OpenAlexW4289108971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.